Uniper reserves NovaSAF capacity from Syzygy Plasmonics in Latin America
- Uniper has reserved future production capacity from Syzygy Plasmonics' NovaSAF platform.
- NovaSAF-1 in Uruguay is approaching a final investment decision.
- NovaSAF converts biogas to sustainable aviation fuel using Syzygy’s Rigel photocatalytic reactor.
- The reserved capacity follows a dual-certified pathway intended to support EU bio and RFNBO SAF mandate targets.
Deal overview
Uniper has reserved future production capacity from Syzygy Plasmonics’ NovaSAF platform, adding to its low‑carbon portfolio and increasing commercial traction for Syzygy’s planned facilities in Central and South America. The agreement is positioned to support the European Union’s ability to meet mandate targets for both bio and RFNBO SAF.
NovaSAF platform
NovaSAF is Syzygy Plasmonics’ commercial project platform that converts biogas to sustainable aviation fuel using the company’s proprietary Rigel photocatalytic reactor. The platform is designed for cost‑competitive production and NovaSAF facilities are planned globally; NovaSAF‑1 in Uruguay is approaching a final investment decision.
Strategic impact
For Uniper, the reservation is a deliberate step in building a low‑carbon energy portfolio that includes SAF. As European aviation faces growing demand under ReFuelEU and CORSIA, securing forward supply from biogas‑to‑SAF pathways is intended to position Uniper to serve customers in a changing market. The agreement follows Uniper’s recent cooperation with Arcadia eFuels on large‑scale eSAF development in Europe.
Source: Uniper